Sanofi, GSK to supply vaccine doses to WHO-backed alliance

  • World
  • Wednesday, 28 Oct 2020

FILE PHOTO: Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs

PARIS (Reuters) - French drugmaker Sanofi and Britain's GlaxoSmithKline will supply 200 million doses of their COVID-19 candidate vaccine to a global inoculation scheme backed by the World Health Organization.

There is no internationally-approved treatment against COVID-19, which has killed more than 1.16 million people, and the two companies' vaccine is still undergoing phase 1 and 2 trials, from which first results are expected by late November or early December.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In World

US, asked about Sikh separatist groups, says it respects free speech
Tunisian police arrest Abir Moussi, prominent opponent of president -lawyer
At least 20 dead in Italian coach crash near Venice, mayor tells local media
1st LD: "At least twenty dead" in bus accident in Venice, says mayor
Urgent: "At least twenty dead" in bus accident in Venice, says mayor
Over 60 Jamaican school kids hospitalized after eating cannabis rainbow candy
WTI crude futures settle higher
Southern California to embrace heat wave this week
U.S. dollar ticks up
Crammed wooden boat with 271 migrants reaches Spain's Canary Islands

Air Pollutant Index

Highest API Readings

    Select State and Location to view the latest API reading

    Source: Department of Environment, Malaysia

    Others Also Read